Business Description
Genedrive PLC
ISIN : GB00B1VKB244
Total Employee Number:
43Description
Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom and also has its presence in Europe, United States of America and Rest of the World.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.77 | |||||
Equity-to-Asset | -0.24 | |||||
Debt-to-Equity | -1.21 | |||||
Debt-to-EBITDA | -0.09 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -27.5 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 43.5 | |||||
3-Year EPS without NRI Growth Rate | 40.6 | |||||
3-Year FCF Growth Rate | 40.6 | |||||
3-Year Book Growth Rate | -65.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 65.24 | |||||
9-Day RSI | 60.97 | |||||
14-Day RSI | 60.44 | |||||
3-1 Month Momentum % | 28.95 | |||||
6-1 Month Momentum % | 41.65 | |||||
12-1 Month Momentum % | -15.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.99 | |||||
Quick Ratio | 0.78 | |||||
Cash Ratio | 0.23 | |||||
Days Sales Outstanding | 146.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -75.5 | |||||
Shareholder Yield % | -6.18 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -584.39 | |||||
Net Margin % | -575.14 | |||||
EBITDA Margin % | -584.39 | |||||
FCF Margin % | -420.13 | |||||
OCF Margin % | -419.05 | |||||
ROE % | -391.62 | |||||
ROA % | -186.93 | |||||
ROIC % | -836.94 | |||||
3-Year ROIIC % | 57.72 | |||||
ROC (Joel Greenblatt) % | -1316.11 | |||||
ROCE % | -357.61 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 6.5 | |||||
PB Ratio | 6.5 | |||||
EV-to-EBIT | -3.83 | |||||
EV-to-Forward-EBIT | 14.77 | |||||
EV-to-EBITDA | -3.87 | |||||
EV-to-Forward-EBITDA | 11.82 | |||||
EV-to-Revenue | 22.59 | |||||
EV-to-Forward-Revenue | 1.23 | |||||
EV-to-FCF | -5.38 | |||||
Earnings Yield (Greenblatt) % | -26.11 | |||||
FCF Yield % | -18.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genedrive PLC Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 0.929 | ||
| EPS (TTM) (£) | -0.008 | ||
| Beta | 4.1635 | ||
| 3-Year Sharpe Ratio | 0.23 | ||
| 3-Year Sortino Ratio | 0.69 | ||
| Volatility % | 355.76 | ||
| 14-Day RSI | 60.44 | ||
| 14-Day ATR (£) | 0.00139 | ||
| 20-Day SMA (£) | 0.012725 | ||
| 12-1 Month Momentum % | -15.52 | ||
| 52-Week Range (£) | 0.0019 - 0.015 | ||
| Shares Outstanding (Mil) | 1,605.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genedrive PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genedrive PLC Stock Events
| Event | Date | Price (£) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-12-31 10:00 | In 178 days | ||
| Annual report for 2026 | 2026-12-08 | In 154 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-12-04 14:00 | In 151 days | ||
| Fourth quarter earnings results for 2026 | 2026-12-04 | In 150 days | ||
| Second quarter earnings results for 2026 | 2026-03-30 | 0.01 (-7.14%) | ||
| General meeting for 2025 | 2025-12-31 10:00 | 0.01 (-3.03%) | ||
| Annual report for 2025 | 2025-12-08 | 0.01 (+2.56%) | ||
| Fourth quarter earnings conference call for 2025 | 2025-12-05 14:00 | 0.01 (-2.50%) | ||
| Fourth quarter earnings results for 2025 | 2025-12-05 | 0.01 (-2.50%) | ||
| Second quarter earnings results for 2025 | 2025-03-27 | 0.02 (-3.95%) |
Show
Entries
Genedrive PLC Frequently Asked Questions
What is Genedrive PLC(LSE:GDR)'s stock price today?
The current price of LSE:GDR is £0.01. The 52 week high of LSE:GDR is £0.02 and 52 week low is £0.00.
When is next earnings date of Genedrive PLC(LSE:GDR)?
The next earnings date of Genedrive PLC(LSE:GDR) is 2026-12-04 Est..
Does Genedrive PLC(LSE:GDR) pay dividends? If so, how much?
Genedrive PLC(LSE:GDR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Genedrive PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers